Generate a tailored SOP for Dr. Sean Pitroda. Improve your application with a focused, well-structured draft.
Sean Pitroda is an Associate Professor at the University of Chicago in the Department of Radiation and Cellular Oncology. His long-term vision is to transform the treatment of metastatic cancer through integrative translational research. He seeks to challenge the prevailing notion that metastases are invariably widespread and incurable. Pitroda believes that a subset of patients with limited metastatic disease can be cured with appropriately tailored therapies. His laboratory integrates molecular profiling, advanced bioinformatics, and immunologic analyses to address pivotal questions relating to curable versus incurable metastatic states and the synergy between radiotherapy and immunotherapy. He has made significant contributions to identifying the biological basis of curable oligometastatic disease, demonstrated tumor aneuploidy as a predictive biomarker for immunotherapy response, and explored the mechanistic basis of how radiation interacts with immune-modifying therapies. His findings have been published in high-impact journals, contributing to the refinement of precision oncology. He has received several awards acknowledging his contributions to tumor biology and radiation oncology.
University of Chicago • Chicago, IL
Teaching and research in the field of radiation and cellular oncology.
Department of Philosophy